|  
Project 
protocol 
— 
Contents 
Workflow 
and 
sampling
 Equipment
 Reagents, 
supplies, 
and 
solutions
 Procedures
 Data
 References
 
 
 Workflow 
and 
sampling 
 
  
Workflow  
 
| Step | Procedure 
performed | Data 
collected |   
| 1 | Body 
weight 
measurement | bw |   
| 2 | Blood 
collection; 
samples 
are 
kept 
at 
24°C 
(for 
<3 
h) 
until 
testing | - |   
| 3 | Peripheral 
blood 
cells 
are 
stained 
and 
counted | % 
lymphocytes, 
% 
neutrophil, 
% 
eosinophils, 
% 
monocytes 
% 
CD4 
T 
cells, 
% 
CD8 
T 
cells, 
% 
memory 
CD4 
T 
cells, 
% 
naive 
CD4 
T 
cells,% 
memory 
CD8 
T 
cells, 
% 
naive 
CD8 
T 
cells, 
% 
NK 
cells, 
% 
B 
cells |  Equipment  
• 
Analytical 
balance: 
Mettler-Toledo, 
Model 
AL54 
(Mettler-Toledo, 
Inc., 
Columbus, 
OH) 
  
 • 
Flow 
cytometers: 
Beckton 
Dickinson 
(BD) 
FACScan 
(BD 
Biosciences, 
San 
Jose, 
CA) 
with 
5-color 
upgrade 
(Cytek 
Development, 
Fremont, 
CA) 
in 
Figures 
A 
and 
C, 
or 
FACS 
Calibur 
(BD 
Biosciences, 
San 
Jose, 
CA) 
in 
Figures 
B 
and 
D 
below. 
  
 Figure 
A: 
Becton 
Dickinson 
FACScan 
setup. 
Figure 
B: 
Becton 
Dickinson 
FACS 
Calibur 
setup. 
Figure 
C: 
BD 
FACScan 
sample 
port. 
Figure 
D: 
BD 
FACS 
Calibur 
sample 
port.
 Reagents, 
supplies, 
solutions 
  
  
Parafilm© 
all-purpose 
laboratory 
film 
(Alcan 
Packaging, 
Neenah, 
WI) 
  
200 
uL 
and 
1000 
uL 
pipette 
tips 
(USA 
Scientific, 
Ocala, 
FL) 
  
Eppendorf® 
tubes 
  
12 
x 
75 
mm 
sample 
tubes 
(USA 
Scientific, 
Ocala, 
FL) 
  
11 
x 
75 
mm 
polypropylene 
(USA 
Scientific 
1450-0000FC) 
or 
polystyrene 
(BD 
Biosciences 
352008) 
tubes 
0.9% 
PBS 
(phosphate 
buffered 
saline 
solution)Hemolytic 
Geys 
buffer 
(J 
Exp 
Med. 
1974 
Oct 
1;140(4):904-20)  
FACS 
Buffer 
(PBS 
with 
2 
mM 
EDTA, 
0.02% 
NaN3, 
and 
2% 
FBS) 
  
Propidium 
iodide 
20 
µg/mL 
solution 
for 
dead 
cell 
exclusion  
Antibody 
cocktail 
for 
B 
cells 
and 
myeloid 
cells: 
CD45R/B220 
APC 
clone 
RA3-6B2
 Gr-1 
APC-Cy7 
clone 
RB6-8C5
 CD11c 
FITC 
clone 
N418
 CD11b/Mac-1 
PE 
clone 
M1/70
 Antibody 
cocktail 
for 
T 
cellsCD3e 
APC-Cy7 
clone 
145-2C11
 CD4 
Cy3 
clone 
GK1.5
 CD8 
PE 
clone 
53-6.7
 CD44 
APC 
clone 
IM7.8.1
 CD62L 
FITC 
clone 
MEL-14
 Antibody 
cocktail 
for 
NK 
cells 
 
NKG2A/C/E 
FITC 
clone 
20d5
 NK1.1 
PE 
clone 
PK136
 Lgl-1 
APC 
clone 
4D11
 CD3e 
APC-Cy7 
clone 
145-2C11
 Antibodies 
are 
purchased 
from 
e-Biosciences 
(San 
Diego, 
CA) 
or 
PharMingen 
(San 
Diego, 
CA). 
 Acclimation 
to 
test 
conditions 
  
In 
general 
all 
mice 
are 
brought 
into 
the 
procedure 
room 
and 
are 
tested 
within 
1h. Procedures  
I. 
Peripheral 
blood 
collectiona. 
A 
mouse 
is 
placed 
on 
a 
scale 
to 
obtain 
body 
weight.
 b. 
Blood 
samples 
are 
collected 
from 
retro-orbital 
plexus 
using 
micro-capillary 
tubes 
and 
stored 
on 
ice. 
Minimum 
required 
blood 
is 
270 
µL 
(about 
12 
drops, 
plus 
one 
capillary 
tube).
 II. 
Whole 
blood 
preparation 
for 
flow 
cytometrya. 
Blood 
samples 
are 
centrifuged 
at 
14,000 
rpm 
for 
5 
min 
at 
4°C 
to 
separate 
cells 
from 
plasma.
 b. 
The 
top 
plasma 
layer 
is 
removed 
and 
stored 
at 
-80°C 
freezer 
for 
different 
experiments. 
The 
cell 
pellet 
is 
re-suspended 
in 
200 
µL 
FACS 
buffer 
and 
transferred 
to 
12 
x 
75 
mm 
polypropylene 
tubes.
 c. 
3 
mL 
hemolytic 
Geys 
solution 
is 
added 
to 
each 
tube, 
incubated 
for 
5 
min 
at 
room 
temperature, 
and 
then 
centrifuged 
at 
500 
x 
g 
for 
5 
min 
to 
separate 
the 
hemolyzed 
red 
blood 
cells.
 d. 
The 
hemolyzed 
red 
cell 
and 
buffer 
layer 
is 
decanted, 
the 
pelleted 
cells 
are 
re-suspend 
in 
additional 
3 
mL 
of 
Geys 
buffer, 
incubated 
for 
3-5 
min 
at 
room 
temperature, 
and 
then 
centrifuged 
again 
at 
500 
x 
g.
 e. 
The 
wash 
buffer 
is 
decanted 
and 
the 
pelleted 
cells 
are 
re-suspend 
in 
4 
mL 
FACS 
buffer 
and 
then 
aliquoted 
into 
3 
new 
tubes 
and 
centrifuged 
at 
500 
x 
g 
for 
5 
min.
 f. 
The 
supernatant 
layer 
is 
decanted 
and 
each 
tube 
of 
pelleted 
cells 
is 
re-suspend 
in 
100 
µL 
of 
FACS 
buffer 
and 
then 
subjected 
to 
staining 
with 
appropriate 
fluorescent-labeled 
antibodies.
 III. 
Peripheral 
blood 
staininga. 
10 
μL 
of 
antibody 
cocktail 
is 
added 
at 
the 
proper 
dilution 
to 
each 
sample*. 
The 
sample 
is 
mixed 
well 
and 
then 
incubated 
on 
ice 
for 
30 
min 
allowing 
the 
cells 
to 
stain.
 b. 
The 
stained 
cells 
are 
washed 
by 
adding 
2.0 
mL 
of 
FACS 
buffer 
to 
each 
tube 
and 
then 
centrifuged 
at 
500 
x 
g 
for 
5 
min 
at 
4°C.
 c. 
The 
supernatant 
is 
decanted 
and 
the 
pelleted 
cells 
is 
re-suspended 
in 
250 
μL 
of 
FACS 
buffer.
 d. 
For 
dead 
cell 
exclusion, 
10 
μL 
of 
propidium 
iodide 
is 
added 
using 
20 
µg/mL 
stock 
solution.
 e. 
FACS 
analysis 
is 
performed 
using 
a 
flow 
cytometer.
 
 * 
All 
antibodies 
are 
titrated 
to 
determine 
optimal 
staining 
levels 
with 
minimum 
background 
staining.
  
IV. 
Peripheral 
blood 
cell 
counts 
acquisition 
 Samples 
are 
acquired 
on 
a 
BD 
FACScan 
(with 
Cytek 
5 
color 
upgrade) 
cytometer 
(see 
Figure 
A 
and 
C 
above) 
or 
BD 
FACS 
Calibur 
(see 
Figures 
B 
and 
D 
above) 
and 
at 
least 
50,000 
live 
events 
are 
collected 
according 
to 
manufacturerâs 
protocol.  
Cautionary 
Note:  
The 
specified 
monoclonal 
antibody 
clones 
used 
in 
this 
study 
have 
not 
been 
tested 
on 
all 
strains. 
It 
is 
possible 
the 
antibodies 
do 
not 
recognize 
all 
isotypes 
of 
the 
marker. 
Thus 
low 
cell 
numbers 
for 
a 
population 
might 
not 
be 
a 
good 
reflection 
of 
the 
actual 
count. V. 
Analysis 
of 
peripheral 
blood 
cell 
countsa. 
Acquired 
cell 
count 
files 
are 
analyzed 
with 
FlowJo 
software 
(TreeStar, 
Inc., 
Ashland, 
OR).
 b. 
Viable 
cells 
are 
gated 
by 
forward 
scatter 
channel 
(FSC) 
and 
exclusion 
of 
propidium 
iodide. 
Red 
blood 
cells 
are 
also 
excluded 
as 
they 
have 
lower 
FSC 
than 
lymphocytes 
(Fig. 
E)
 c. 
Lymphocytes 
are 
gated 
from 
the 
viable 
cells 
by 
FSC 
versus 
SSC 
(sides 
scatter 
channel) 
for 
T 
cells, 
B 
cells, 
and 
NK 
cells 
(Fig. 
F).
 d. 
B 
cells 
are 
gated 
from 
the 
lymphocytes 
as 
positive 
for 
the 
CD45R/B220 
antigen 
(B220+ 
cells) 
(Fig. 
G).
  

 e. 
T 
cells 
are 
gated 
from 
the 
lymphocyte 
gate 
on 
the 
basis 
of 
CD3 
and 
CD4 
expression 
for 
CD4+ 
T 
cells 
("T 
helper"), 
and 
CD3 
and 
CD8 
expression 
for 
CD8+ 
T 
cells 
("cytotoxic") 
(Fig. 
H). 
f. 
CD4+ 
and 
CD8+ 
T 
cell 
subsets 
are 
gated 
for 
CD44 
and 
CD62L. 
The 
memory 
and 
naive 
cells 
are 
defined 
as: 
CD44 
high, 
CD62L 
low 
(effector 
memory), 
CD44 
high, 
CD62L 
high 
(central 
memory), 
CD44 
low, 
CD62L 
low, 
and 
CD44 
low, 
CD62L 
high 
(naive) 
(Fig. 
I)
  

 g. 
NK 
cells 
are 
reported 
as 
CD3â 
cells 
divided 
into 
3 
subgroups: 
Lgl-1+, 
NK1.1+, 
and 
NKG2A/C/E+ 
(Figs. 
J, 
K, 
and 
L). 
Total 
NK 
cells 
are 
cells 
which 
fall 
in 
any 
of 
those 
three 
gates.  

 h. 
Granulocytes 
are 
gated 
as 
CD11b+ 
Gr-1 
high 
and 
SSC 
high 
(Fig. 
M 
and 
Fig. 
N). 
Eosinophils 
are 
gated 
as 
Gr-1 
mid 
to 
low, 
SSC 
very 
high, 
and 
CD11b 
mid 
to 
high 
(Fig. 
N). 
i. 
Monocytes 
are 
gated 
as 
CD11b+ 
and 
SSC 
low 
(as 
compared 
to 
granulocytes). 
Inflammatory 
monocytes 
are 
gated 
as 
CD11b+CD11câGr-1 
mid. 
Resident 
monocytes 
are 
gated 
as 
CD11b+, 
CD11c+, 
Gr-1â 
cells 
(Fig. 
O).
  

 Note: 
The 
percentage 
of 
each 
population 
of 
viable 
cells 
is 
reported. 
The 
percent 
of 
viable 
cells 
of 
total 
is 
not 
the 
same 
as 
% 
cell 
viability, 
as 
the 
total 
includes 
red 
cells 
and 
debris 
in 
addition 
to 
dead 
cells.
 Data 
collected 
by 
investigator  
% 
lymphocytes, 
% 
B 
cells, 
% 
CD4 
T 
cells, 
% 
memory 
CD4 
T 
cells, 
% 
naive 
CD4 
T 
cells, 
% 
CD8 
T 
cells, 
% 
memory 
CD8 
T 
cells, 
% 
naive 
CD8 
T 
cells, 
% 
NK 
cells, 
% 
granulocytes, 
% 
eosinophils, 
and 
% 
monocytes 
from 
peripheral 
blood 
of 
6 
month-old 
mice. 
 
 References
| 
Julius MH, Herzenberg LA. Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities. J Exp Med. 1974 Oct 1;140(4):904-20.
PubMed 4139227
  FullText
 | 
 |